The_DT
RAR-RXR_NN
as_RB
well_RB
as_IN
the_DT
RXR-RXR_JJ
pathway_NN
is_VBZ
involved_VBN
in_IN
signaling_NN
growth_NN
inhibition_NN
of_IN
human_JJ
CD34_NN
+_CC
erythroid_JJ
progenitor_NN
cells_NNS
._.

Previous_JJ
studies_NNS
have_VBP
shown_VBN
that_IN
retinoic_JJ
acid_NN
-LRB-_-LRB-
RA_NN
-RRB-_-RRB-
,_,
similar_JJ
to_TO
tumor_NN
necrosis_NN
factor-alpha_NN
-LRB-_-LRB-
TNF-alpha_NN
-RRB-_-RRB-
,_,
can_MD
act_VB
as_IN
a_DT
bifunctional_JJ
regulator_NN
of_IN
the_DT
growth_NN
of_IN
bone_NN
marrow_NN
progenitors_NNS
,_,
in_IN
that_WDT
it_PRP
can_MD
stimulate_VB
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
-LRB-_-LRB-
GM-CSF_NN
-RRB-_-RRB-
-_:
or_CC
interleukin-3_NN
-LRB-_-LRB-
IL-3_NN
-RRB-_-RRB-
-_:
induced_VBD
GM_NN
colony_NN
formation_NN
,_,
but_CC
potently_RB
inhibit_VB
G-CSF-induced_JJ
growth_NN
._.

The_DT
present_JJ
study_NN
,_,
using_VBG
highly_RB
enriched_VBN
human_JJ
CD34_NN
+_CC
as_RB
well_RB
as_IN
Lin_NN
-_:
murine_JJ
bone_NN
marrow_NN
progenitor_NN
cells_NNS
,_,
demonstrates_VBZ
a_DT
potent_JJ
inhibitory_JJ
effect_NN
of_IN
9-cis-RA_NN
on_IN
burst-forming_JJ
unit-erythroid_NN
-LRB-_-LRB-
BFU-E_NN
-RRB-_-RRB-
colony_NN
formation_NN
regardless_RB
of_IN
the_DT
cytokine_NN
stimulating_VBG
growth_NN
._.

Specifically_RB
,_,
9-cis-RA_NN
potently_RB
inhibited_VBD
the_DT
growth_NN
of_IN
BFU-E_NN
response_NN
to_TO
erythropoietin_NN
-LRB-_-LRB-
Epo_NN
-RRB-_-RRB-
-LRB-_-LRB-
100_CD
%_NN
-RRB-_-RRB-
,_,
stem_NN
cell_NN
factor_NN
-LRB-_-LRB-
SCF_NN
-RRB-_-RRB-
+_CC
Epo_NN
-LRB-_-LRB-
92_CD
%_NN
-RRB-_-RRB-
,_,
IL-3_NN
+_CC
Epo_NN
-LRB-_-LRB-
97_CD
%_NN
-RRB-_-RRB-
,_,
IL-4_NN
+_CC
Epo_NN
-LRB-_-LRB-
88_CD
%_NN
-RRB-_-RRB-
,_,
and_CC
IL-9_NN
+_CC
Epo_NN
-LRB-_-LRB-
100_CD
%_NN
-RRB-_-RRB-
._.

Erythroid_JJ
colony_NN
growth_NN
was_VBD
also_RB
inhibited_VBN
when_WRB
CD34_NN
+_CC
progenitors_NNS
were_VBD
seeded_VBN
at_IN
one_CD
cell_NN
per_IN
well_NN
,_,
suggesting_VBG
a_DT
direct_JJ
action_NN
of_IN
RA_NN
._.

Using_VBG
synthetic_JJ
ligands_NNS
to_TO
retinoic_JJ
acid_NN
receptors_NNS
-LRB-_-LRB-
RARs_NNS
-RRB-_-RRB-
and_CC
retinoid_NN
X_NN
receptors_NNS
-LRB-_-LRB-
RXRs_NNS
-RRB-_-RRB-
that_WDT
selectively_RB
bind_VBP
and_CC
activate_VBP
RAR-RXR_NN
or_CC
RXR-RXR_JJ
dimers_NNS
,_,
respectively_RB
,_,
we_PRP
dissected_VBD
the_DT
involvement_NN
of_IN
the_DT
two_CD
retinoid_NN
response_NN
pathways_NNS
in_IN
the_DT
regulation_NN
of_IN
normal_JJ
myeloid_JJ
and_CC
erythroid_JJ
progenitor_NN
cell_NN
growth_NN
._.

Transactivation_NN
studies_NNS
showed_VBD
that_IN
both_CC
the_DT
RAR_NN
-LRB-_-LRB-
Ro_NN
13-7410_CD
-RRB-_-RRB-
and_CC
RXR_NN
-LRB-_-LRB-
Ro_NN
25-6603_CD
and_CC
Ro_NN
25-7386_CD
-RRB-_-RRB-
ligands_NNS
were_VBD
highly_RB
selective_JJ
at_IN
100_CD
nmol\/L_NN
._.

At_IN
this_DT
concentration_NN
,_,
Ro_NN
13-7410_CD
potently_RB
inhibited_VBD
G-CSF-stimulated_NN
myeloid_JJ
as_RB
well_RB
as_IN
SCF_NN
+_CC
Epo-induced_JJ
erythroid_JJ
colony_NN
growth_NN
._.

At_IN
the_DT
same_JJ
concentration_NN
,_,
Ro_NN
25-6603_CD
and_CC
Ro_NN
25-7386_CD
had_VBD
little_JJ
or_CC
no_DT
effect_NN
on_IN
G-CSF-induced_JJ
colony_NN
formation_NN
,_,
whereas_IN
they_PRP
inhibited_VBD
75_CD
%_NN
and_CC
53_CD
%_NN
,_,
respectively_RB
,_,
of_IN
SCF_NN
+_CC
Epo-stimulated_JJ
BFU-E_NN
colony_NN
growth_NN
._.

Thus_RB
,_,
the_DT
RAR-RXR_JJ
response_NN
pathway_NN
can_MD
signal_VB
growth_NN
inhibition_NN
of_IN
normal_JJ
bone_NN
marrow_NN
myeloid_JJ
and_CC
erythroid_JJ
progenitor_NN
cells_NNS
._.

In_IN
addition_NN
,_,
we_PRP
demonstrate_VBP
a_DT
unique_JJ
involvement_NN
of_IN
the_DT
RXR-RXR_JJ
pathway_NN
in_IN
mediating_VBG
growth_NN
inhibition_NN
of_IN
erythroid_JJ
but_CC
not_RB
myeloid_JJ
progenitor_NN
cells_NNS
._.

